Cargando…
Systematic review of incretin therapy during peri-operative and intensive care
BACKGROUND: Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) are incretin hormones. By lowering blood glucose in a glucose-dependent manner, incretin-based therapies represent a novel and promising intervention to treat hyperglycaemia in hospital settings. We perfor...
Autores principales: | Hulst, Abraham H, Plummer, Mark P, Hollmann, Markus W, DeVries, J Hans, Preckel, Benedikt, Deane, Adam M, Hermanides, Jeroen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236901/ https://www.ncbi.nlm.nih.gov/pubmed/30428906 http://dx.doi.org/10.1186/s13054-018-2197-4 |
Ejemplares similares
-
Study protocol of a randomised controlled trial comparing perioperative intravenous insulin, GIK or GLP-1 treatment in diabetes–PILGRIM trial
por: Polderman, Jorinde AW, et al.
Publicado: (2014) -
Effects of Hyperglycemia and Diabetes Mellitus on Coagulation and Hemostasis
por: Li, Xiaoling, et al.
Publicado: (2021) -
Study protocol of the randomised placebo-controlled GLOBE trial: GLP-1 for bridging of hyperglycaemia during cardiac surgery
por: Hulst, Abraham H, et al.
Publicado: (2018) -
Liraglutide for perioperative management of hyperglycaemia in cardiac surgery patients: a multicentre randomized superiority trial
por: Hulst, Abraham H., et al.
Publicado: (2019) -
Second Update for Anaesthetists on Clinical Features of COVID-19 Patients and Relevant Management
por: Weenink, Robert P., et al.
Publicado: (2020)